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= Abstract = To assess the prognostic significance of Human papillomavirus 
(HPV) type 16 and 18 which have been supposed as high risk oncogenic viruses 
in cervical cancer, polymerase chain reaction(PCR) was used to determine HPV 
type in formalin fixed paraffin embedded tissue blocks. Samples w r e  obtained 
from patients with stage 1 and I1 cervical cancer who underwent surgery from 
1985 to 1986 a t  Seoul National University Hospital. In total 65 patients were enlis- 
ted, but 9 patients w r e  excluded in data analysis because of poor amplification of 
fi-globin during the PCR procedure. Cilnicopathologic factors (age, stage, histologic 
type, tumor size, lymph node metastasis) and 5 year survival rate were compared 
between HPV positive and HPV negative groups. The survival difference betwen 
HPV 16 positive and HPV 18 positive cases was also analyed. HPV 16 /18 posi- 
tiw rate in cervical cancer is 80.4% (45 /56), and there is no significant difference 
in age, stage, histologic type, tumor size, nodal metastasis by HPV infection stat- 
us. No difference was found in 5 year survival rate between HPV positive and neg- 
atiw groups. When compared with the HPV 16 positive group, the HPV 18 posi- 
tiw group did not show any difference in prognosis. These data suggested that the 
presence of HPV 16 or HPV 18 in cervical cancer had no relation with known 
prognostic factors. Either HPV positivity or HPV type (HPV 16 us. HPV 18) did not 
haw any prognostic significance in cervical cancer. 
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INTRODUCTION 
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(02-93-098) !LEZ 01 Fq 4 2 9. Invasive cancer of the uterine cervix is the 
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qkg, 7J+%, 0 J j Z S  ea. Epidemiologic studies suggest that cervical 
g ~ q q z  q q i q q  +;o~qq;17.g : qgq cancer is a sexually transmitted disease (Reeves 
et a/. ,  1989; Slattery et a/.,  1989; Syrjanen K, 
1989) and Human papillomavirus (HPV) may 
play a major role in the development of this d~s-  
ease (Lancaster WD et a/ . ,  1986; Ostrow RS et 
a/ . ,  1987; Xiao X et a/.,  1988; Syrjanen K, 1989; 
Zur Hausen H, 1989). Until now over 65 HPV 
types have been identified and type 16 and 18 
are suspected to have high oncogenic potentla1 
and be the most prevalent types in cervical can- 
cer (Class ECJ, 1989 ; Young LS et al., 1989 ; Ji 
HX, 1990). Shibata et a/.  (1988), described pol- 
ymerase chain reaction in paraffin embedded tis- 
sues which is a highly sensitive method for HPV 
typing. This technology made it possible to de- 
tect HPV in old tissue samples and to compare 
tumor histology and HPV viral DNA in the same 
specimen. The association of these viruses with 
known high risk prognostic factors and survival 
rate has been under study but remains to be 
established (Gordon AN et a/ . ,  1989; King LA et 
a/ . ,  1989; Liou G et a/ . ,  1990; Walker J et a/ . ,  
1989; Ji HX et a/ . ,  1991 ; Maureen AJ et a/ . ,  
1992; Ulla Hording et a/.,  1992). Some reports 
suggested that HPV type 18 related cervical can- 
cer showed poorer prognosis than HPV 16 as- 
sociated cancer, further studies are needed to 
come to a conclusion. If the presence of these 
oncogenlc HPV in cervix cancer was associated 
with invasiveness and patient's survival, it would 
be possible to use these biologic data in the 
management of cervical cancer. To test the 
above hypothesis in this retrospective study, we 
obtained HPV 16 and 18 DNA prevalence rates 
in cervical cancer tissues. The relationship be- 
tween the presence of HPV DNA and patient's 
prognostic factors was analyzed, and survival 
rate according to HPV positivity and HPV type 
were compared. 
MATERIALS AND METHODS 
Study group 
lnvasive cervical cancer patients who were 
surgically treated at the Department of Obstet- 
rics and Gynecology, Seoul National University 
Hospital from Feburary 1985 to December 1986 
were identified from the tumor registry. Their pat- 
hologic files were reviewed and 65 cervical can- 
cer specimens were selected among them. The 
Hematoxyline-eosin (H-E) sjained sections of the 
paraffin embedded tissues(PETs) were histologic- 
ally reassessed by a pathologist and tissue bloc 
ks which showed the largest percentage of tum- 
or with the least amount of necrotic debris were 
chosen. 50pm sections from each block for 
PCR and 5pm sections for H-E staining were 
made to confirm histology. 9 cases were exclud- 
ed due to failure of ,8-globin expression during 
the PCR procedure, therefore the remaining 56 
cases were included in data analysis. Data were 
compiled regarding HPV status, clinico-patho- 
logic findings, and survival for these patients. 
Sample preparation 
DNA extraction from the paraffin embedded 
tissue sections was done according to the met- 
hod as described by Wright and Manos(Wright 
DK, 1990). The 50pm tissue section was placed 
in a 0.5 ml polypropylene tube and deparaffin- 
ized in xylene at 37°C for 30 minutes, centrif- 
uged twice at 6,000 rpm for 3 minutes, washed 
twice in 1 ml absolute ethanol for 30 minutes 
and air dried. The sample was digested in 100,d 
of buffer containing 10mM Tris-HCI, 1 mM EDTA, 
0.5 % Tween 20, and Proteinase-K 5 pI (2 mglml). 
After incubation at 50°C for 2 hours, and 95°C 
for 5 minutes to inactivate the protease, the 
sample was centrifuged briefly and the super- 
natant was frozen at -20°C for later PCR am- 
plification. 
PCR amplification 
10pl of sample supernatant was added to the 
90pI PCR reaction buffer solution to a total vol- 
ume of 100p1 containing 100pM of each of the 
four nucleotide triphosphates, 20mM Tris HCI 
(pH 8.3), 1.5mM MgC12, 25mM KCI, 0.05% 
Tween 20, 1 IU of Taq polymerase. The reaction 
mixture included 0.25pM each of a pair of syn- 
thetic primers specific either for a 260 bp se- 
quence of the human ,8-globin genome (Internal 
control), for a 120bp region of the HPV 16 gen- 
ome, or for a 100 bp region of HPV 18. Primers 
were supplied from Clontech Co. (Palo Alto, Cal- 
ifornia, USA) (Table 1 ) .  The samples were over- 
laid with drops of mineral oil to prevent 
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Table 1. Sequences of oligonucleotide primers 
HPVa type Sequence(5'-3') Genomic location Size of amplified 
Products (bp) 
Type specific primersb 
HPV 16 A : TCAAAAGCCACTGTGTCCTG 42 1 -440 
B : CGTGTTCTTGATGATCTGCA 521 -540 
HPV 18 A : ACCTTAATGAAAAACGACGA 463-482 
B : CGTCGTTGGAGTCGTTCCTG 543-562 
b-globin primerc 
: GAAGAGCCAAGGACAGGTAC 
B~ : CAACTTCATCCACGTTCACC 
a : Human Papillomavirus 
b .  Data from Young LS et al. 
: Data from Resnick et al. 
" A : Upstream primer, B : Downstream primer 
evaporation and subjected to 35 cycles of am- 
plification in a DNA thermal cycler (Hybaid ther- 
mal reactor: Hybaid Ltd., U.K.). Each cycle con- 
sists of a 96°C denaturation step of 60 seconds, 
a 56°C primer annealing step of 60 seconds, 
and a 72°C primer extension step of 120 sec- 
onds. In the first cycle the denaturation step ex- 
tended to 5 minutes at 9672, and in the final 
cycle the primer extension step was prolonged 
to 5 minutes at 72°C. 
Electrophoresis and DNA staining 
lop1 of each PCR mixture was loaded onto 
an 8 % polyacrylamide gel and electrophoresis 
carried out. The gel was stained in 1 pllml ethid- 
ium bromide solution for 30 minutes and visu- 
ally inspected under ultraviolet light and phot- 
ographed by black and white polaroid (ASA 
3000). 
Statistical analysis 
Student's t-test was used to examine the dif- 
ference in mean age and average tumor size 
between HPV type 16 or type 18 positive group 
and HPV negative group. The relationship be- 
tween HPV status and patient chracteristics 
such as age (<50 vs. 250 ) ,  histologic type 
(squamous cell carcinoma vs. adeno or aden- 
osquamous cell carcinoma), tumor size(< 3cm 
vs. >3cm),  L/N metastasis(positive vs. negative) 
was examined using Chi-square or Fisher's exact 
test. Cochran-Mantel-Haenszel test was used to 
see linear association between HPV status and 
stage. 5 year survival estimates were based on 
Kaplan-Meier method and the comparison of 
survival by HPV status was made by Log-rank 
test. The above analyses were performed using 
SAS statistical software and considered to be 
significant if P-value <0.05. 
RESULTS 
9 cases were excluded because B-globin was 
not amplified and the remaining 56 cases were 
included in data analysis. HPV 16 and 18 DNA 
positive rate was 42/56 (75.0% ) and 9/56 (1 6.1 
%)  respectively. Total HPV positive rate 80.4% 
(45156) and both types were positive in 6 cases. 
There is no difference in the clinicopathologic 
characteristics between the HPV positive group 
and the HPV negative group except for average 
umor size (Table 2). There is no significant differ- 
ence in 5 year survival rate according to the ab- 
sence or presence of HPV(80% vs 75.7%) and 
this fact also applied to HPV type between HPV 
1 6 and 18 (75.9 % vs 71.4 % ) (Table 3) (P> 0.05). 
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Table 2. Clinicopathologic characteristics of patients according to HPV status 
Variable 
Number HPVa ( + ) cases HPV ( - )  cases 
o f P-Value 













Tumor size(No. = 51 ) 
mean 
S.D. 
1 3 c m  
>3cm 
L I N  metastasis 
Positive 
Negative 
" : Human papillomavirus 
b :  Student t-test 
" :  x2 test or Fisher's exact test 
d :  Cochrane Mantel Haenszel test 
DISCUSSION 
While the definite etiologic role of human pap- 
illomavirus in the carcinogenesis of cervical can- 
cer is still unknown, a strong association with 
HPV type 16 and 18 has been established. Pol- 
ymerase chain reaction (PCR) has been w~dely 
used as a sensitive HPV detection method In 
various specimens such as cervical scrapes, par- 
affin embedded tissues and so on. The ava~l-  
ability of HPV detection in paraffin-embedded 
tissues by PCR method provides the opportunity 
to study previously treated patients retrospectiv- 
ely. There has been concern about the prog- 
nostic value of HPV in cervical carcinoma and 
arguments about this issue. Some reports said 
that HPV infection is not associated with age, 
stage, tumor grade, lymph node metastasis sur- 
vival (King LA et a/., 1989; Ji H X  et a/. ,  1991 ) ,  
but others found that HPV positive patients had 
a better prognosis than HPV negative counter- 
parts(Riou G et a/., 1990). It has also been sug- 
gested that certain HPV types, especially type 
18, were related to poor clinical outcome and 
poor prognosis (Walker J et a/., 1989, Arends MJ 
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Table 3. 5 year survival est~mates by stage and HPVa status 
Var~able 










Type 18( + ) 
- - -- -- -- 
' Human pap~l lomav~rus 
" not slgnlflcant 
number 
of cases 
- -  - -- . . 
45 
11 
Type 16( + 
9 
estimated 5 year 
survival rate(% ) 
univariate 
log-rank test 
Fig. 1 Polyacrylamlde gel electrophores~s following polymerase chaln reactlon(PCR) wlth control samples 
Lane M Slze marker, 
Lane C Cask1 cell DNA (pos~tlve control for HPV 16), 
Lane H HeLa cell DNA (pos~tlve control for HPV 181, 
Lane C + H Mlxture of CasKl and HeLa cell DNA, 
Lane N Neuroblastoma (Negative controls), 
Lane 1-14 DNA samples from cervlx cancer patlents 
et a / ,  1993) In the pre, 7 t  study, HPV 16/18 
DNA was found In 80 4 '/o (45156) and both 
types were pos~tlve In 6 cases There was no 
relat~onsh~p between HPV poslt~v~ty and clln~cop- 
athologlc and prognost~c factors such as age, 
stage, h~stolog~c type, tumor slze, LIN metasta- 
sls No surv~val difference was noted between 
HPV pos~tlve and negatlve groups, both had 
approx~mately a 75 O/O 5 year survival rate. Con- 
sidering all the facts above, HPV 16 or 18 DNA 
positivity could not be regarded as a prognostic 
factor, and cervix cancer with HPV DNA did not 
show a poorer prognosis than HPV negative 
cancer. Kurman RJ et a / .  (1988), suggested that 
HPV 18 might have higher oncogenic potential 
because t h ~ s  type is more frequently found in 
quently. We could not find any evidence that 
HPV 18 harboring tumor had a more invasive 
character or higher risk of metastasis or poorer 
prognosis than HPV 16 or non-HPV associated 
cervical cancer. The Association of HPV 18 with 
adenocarcinoma has also been reported (Wil- 
czynski SP et a/ . ,  1988; Tase T et a/.,  1989; Wal 
ker J et a/., 1989; Riou G et a/., 1990), but our 
data did not show this. 
Even though there is general agreement 
about the concept of an intimate relationship 
between HPV and cervical cancer carcinogen- 
esis, the presence of their DNA in cancer tissue 
does not seem to have prognostic significance. 
HPV 18 harboring tumor does not have a more 
invasive character nor does it show a poorer 
prognosis than its HPV 16 positive counterpart. 
The extension and improvement of the polymer- 
ase chain reaction method, such as quantitative 
B: HPV NEGATIVE CERVIX CANCER(N=I I ) 
Fig. 2. 5 year survival rate by presence of hu- 
man papillomavirus(HPV) 
biopsies from cervical carcinoma than from 
intraepithelial lesions, while HPV 16 was seen at 
equal frequencies. Walker et al(1989) dem- 
onstrated that patients with HPV 18 containing 
tumor tended to have recurrences more fre- 
Table 4. 5 year survival estimates by clinical stage and HPV status 
Number 
Variable 
censored estimated 5 year U nivariate 









Tumor size(N -51 ) 
< 3 cm 








Type 16( + )  
Type 18( + )  
X2 test or F~sher's exact test 
@ Cochrane Mantel Haenszel test 
Table 5. Survival rate by HPV DNA positivity related to age, stage, histologic type, tumor size, depth 
of invasion, lymph node metastasis. 
Number HPV ( + )  cases (%) HPV types 
o f P-Value Variable 
cases Number percentage HPV 16 HPV 18 
Age (n =61)" 
< 50 3 1 
2 50 30 
Stage(n =61 )b  
0 5 
la 5 








Tumor size(N = 51 )" 
5 3  cm 2 8 
> 3cm 2 3 
Depth of invasion (N =55) 
inner 1 13 2 0 
middle 113 10 
outer 113 13 




a X2 test 
b Kendall's tau test 
PCR, will make it possible to define the prog- 
nostic significance of HPV more clearly. 
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